ALHC SEC Filing News — Alignment Healthcare, Inc.

Latest SEC filings for Alignment Healthcare, Inc. (ALHC) explained in plain English. Covers insider buying and selling (Form 4), proposed insider sales (Form 144), material company events (8-K), and quarterly & annual reports (10-Q / 10-K). StrongBuyAnalytics provides navigation and brief excerpts or summaries; original filings remain at the SEC/source links and were authored by their filers, not StrongBuyAnalytics. Filing dates shown are source dates. Coverage and detection can be delayed or incomplete because of SEC availability, amendments, parsing, caching, or outages. Latest source filing date shown: 2026-10-08.

Alignment Healthcare, Inc. operates a consumer-centric healthcare platform for seniors in the United States. It delivers customized healthcare experience to meet the needs of seniors through its Medicare Advantage plans. Alignment Healthcare, Inc. was founded in 2013 and is based in Orange, California.
Sector: Healthcare Industry: Healthcare Plans Market Cap: $1.7B
20
Total Filings
0
Bullish Classifications
12
Bearish Classifications
9
Insider Transactions
2
Material Events (8-K)
1
Periodic Reports
Rule-based classifications for ALHC currently lean bearish. Of the 20 filing records displayed, 12 carry bearish classifications (such as insider sales or negative 8-K disclosures) versus 0 bullish. This does not necessarily signal fundamental deterioration — insiders sell for many reasons — but it is worth monitoring alongside the company's core financial metrics.
ALHC Filing Activity Snapshot 2026-07-10 — 2026-10-08
Insider Transactions (Form 4)
0 buys vs 9 sells
Net insider selling in this period — insiders sell for many reasons beyond conviction.
Largest Form 144 Filing
$12.53M
JEK TRUST U/A DTD 02/08/2021 · 2026-07-10
596,000 shares · Form 144
Form 144 Notices
8
Proposed insider sales filed — Form 144 is a notice of intent, not a confirmed transaction. Actual sales are confirmed via Form 4.
Insider Transactions 9 · Forms 3, 4 and 5

A Form 4 is filed within two business days of a company insider — an officer, a director, or a holder of more than ten percent of the stock — changing their position in the shares. All 9 filings in this group are Form 4s for Alignment Healthcare, Inc.

The difficulty with reading these filings as a group is that a single form type covers transactions that mean entirely different things. An executive spending their own money to buy stock and an executive having shares withheld to pay tax on a vesting grant both appear as a Form 4. Every filing below is therefore tagged with the nature of the underlying transaction, taken from the transaction code reported on the form itself.

Across the 9 insider filings shown, the breakdown is 9 open-market sale. 9 of them involved a discretionary open-market trade; the rest are compensation and administrative mechanics.

What each transaction type means

Open-market sale ×9
The insider sold shares on the open market. Sales may be discretionary or executed automatically under a pre-arranged Rule 10b5-1 trading plan, and a Form 4 does not always make clear which applies.
Form 4 Open-market sale Insider Selling 2026-10-07

ALHC insider Kim Hyong (Chief Medical Officer) sold 32,479 shares (~$269.6K)

Kim Hyong, listed as Chief Medical Officer at Alignment Healthcare, Inc., reported an open-market sale of 32,479 ALHC shares in a Form 4 filing. This is a confirmed insider sale, not just a proposed sale notice.

The insider sold shares on the open market. Sales may be discretionary or executed automatically under a pre-arranged Rule 10b5-1 trading plan, and a Form 4 does not always make clear which applies.

Transactions reported on this filing
Code Nature Shares Price Value
S Open-market sale 32,479 $8.30 $269.6K
Filing: Form 4 (Insider Transaction) Insider: Kim Hyong (Chief Medical Officer) Shares: 32,479 Est. Value: $269.6K
View on SEC EDGAR → Open Filing Document →
Form 4 Open-market sale Insider Selling 2026-09-18

ALHC insider KONOWIECKI JOSEPH S (Director, EVP, Corporate Affairs) sold 23,511 shares (~$202.4K)

KONOWIECKI JOSEPH S, listed as Director, EVP, Corporate Affairs at Alignment Healthcare, Inc., reported an open-market sale of 23,511 ALHC shares in a Form 4 filing. This is a confirmed insider sale, not just a proposed sale notice.

The insider sold shares on the open market. Sales may be discretionary or executed automatically under a pre-arranged Rule 10b5-1 trading plan, and a Form 4 does not always make clear which applies.

Transactions reported on this filing
Code Nature Shares Price Value
S Open-market sale 23,511 $8.61 $202.4K
Filing: Form 4 (Insider Transaction) Insider: KONOWIECKI JOSEPH S (Director, EVP, Corporate Affairs) Shares: 23,511 Est. Value: $202.4K
View on SEC EDGAR → Open Filing Document →
Form 4 Open-market sale Insider Selling 2026-09-16

ALHC insider KAO JOHN E (Director, Chief Executive Officer) sold 27,400 shares (~$356.2K)

KAO JOHN E, listed as Director, Chief Executive Officer at Alignment Healthcare, Inc., reported an open-market sale of 27,400 ALHC shares in a Form 4 filing. This is a confirmed insider sale, not just a proposed sale notice.

The insider sold shares on the open market. Sales may be discretionary or executed automatically under a pre-arranged Rule 10b5-1 trading plan, and a Form 4 does not always make clear which applies.

Transactions reported on this filing
Code Nature Shares Price Value
S Open-market sale 27,400 $13.00 $356.2K
Filing: Form 4 (Insider Transaction) Insider: KAO JOHN E (Director, Chief Executive Officer) Shares: 27,400 Est. Value: $356.2K
View on SEC EDGAR → Open Filing Document →
Form 4 Open-market sale Insider Selling 2026-09-11

ALHC insider Maroney Dawn Christine (President) sold 122,707 shares (~$1.56M)

Maroney Dawn Christine, listed as President at Alignment Healthcare, Inc., reported an open-market sale of 122,707 ALHC shares in a Form 4 filing. This is a confirmed insider sale, not just a proposed sale notice.

The insider sold shares on the open market. Sales may be discretionary or executed automatically under a pre-arranged Rule 10b5-1 trading plan, and a Form 4 does not always make clear which applies.

Transactions reported on this filing
Code Nature Shares Price Value
S Open-market sale 122,707 $12.68 $1.56M
Filing: Form 4 (Insider Transaction) Insider: Maroney Dawn Christine (President) Shares: 122,707 Est. Value: $1.56M
View on SEC EDGAR → Open Filing Document →
Form 4 Open-market sale Insider Selling 2026-09-11

ALHC insider KAO JOHN E (Director, Chief Executive Officer) sold 557,870 shares (~$7.12M)

KAO JOHN E, listed as Director, Chief Executive Officer at Alignment Healthcare, Inc., reported an open-market sale of 557,870 ALHC shares in a Form 4 filing. This is a confirmed insider sale, not just a proposed sale notice.

The insider sold shares on the open market. Sales may be discretionary or executed automatically under a pre-arranged Rule 10b5-1 trading plan, and a Form 4 does not always make clear which applies.

Transactions reported on this filing
Code Nature Shares Price Value
S Open-market sale 172,600 $12.96 $2.24M
S Open-market sale 385,270 $12.68 $4.89M
Filing: Form 4 (Insider Transaction) Insider: KAO JOHN E (Director, Chief Executive Officer) Shares: 557,870 Est. Value: $7.12M
View on SEC EDGAR → Open Filing Document →
Form 4 Open-market sale Insider Selling 2026-08-18

ALHC insider Maroney Dawn Christine (President) sold 5,000 shares (~$70.0K)

Maroney Dawn Christine, listed as President at Alignment Healthcare, Inc., reported an open-market sale of 5,000 ALHC shares in a Form 4 filing. This is a confirmed insider sale, not just a proposed sale notice.

The insider sold shares on the open market. Sales may be discretionary or executed automatically under a pre-arranged Rule 10b5-1 trading plan, and a Form 4 does not always make clear which applies.

Transactions reported on this filing
Code Nature Shares Price Value
S Open-market sale 5,000 $14.00 $70.0K
Filing: Form 4 (Insider Transaction) Insider: Maroney Dawn Christine (President) Shares: 5,000 Est. Value: $70.0K
View on SEC EDGAR → Open Filing Document →
Form 4 Open-market sale Insider Selling 2026-08-10

ALHC insider KAO JOHN E (Director, Chief Executive Officer) sold 298,000 shares (~$4.14M)

KAO JOHN E, listed as Director, Chief Executive Officer at Alignment Healthcare, Inc., reported an open-market sale of 298,000 ALHC shares in a Form 4 filing. This is a confirmed insider sale, not just a proposed sale notice.

The insider sold shares on the open market. Sales may be discretionary or executed automatically under a pre-arranged Rule 10b5-1 trading plan, and a Form 4 does not always make clear which applies.

Transactions reported on this filing
Code Nature Shares Price Value
S Open-market sale 298,000 $13.88 $4.14M
Filing: Form 4 (Insider Transaction) Insider: KAO JOHN E (Director, Chief Executive Officer) Shares: 298,000 Est. Value: $4.14M
View on SEC EDGAR → Open Filing Document →
Form 4 Open-market sale Insider Selling 2026-07-16

ALHC insider Maroney Dawn Christine (President) sold 177,068 shares (~$3.69M)

Maroney Dawn Christine, listed as President at Alignment Healthcare, Inc., reported an open-market sale of 177,068 ALHC shares in a Form 4 filing. This is a confirmed insider sale, not just a proposed sale notice.

The insider sold shares on the open market. Sales may be discretionary or executed automatically under a pre-arranged Rule 10b5-1 trading plan, and a Form 4 does not always make clear which applies.

Transactions reported on this filing
Code Nature Shares Price Value
M Option exercise 152,068 $9.06 $1.38M
S Open-market sale 177,068 $20.83 $3.69M
M Option exercise derivative · Options (Right to Buy) 152,068 $9.06 $1.38M
Filing: Form 4 (Insider Transaction) Insider: Maroney Dawn Christine (President) Shares: 177,068 Est. Value: $3.69M
View on SEC EDGAR → Open Filing Document →
Form 4 Open-market sale Insider Selling 2026-07-14

ALHC insider KAO JOHN E (Director, Chief Executive Officer) sold 298,000 shares (~$5.92M)

KAO JOHN E, listed as Director, Chief Executive Officer at Alignment Healthcare, Inc., reported an open-market sale of 298,000 ALHC shares in a Form 4 filing. This is a confirmed insider sale, not just a proposed sale notice.

The insider sold shares on the open market. Sales may be discretionary or executed automatically under a pre-arranged Rule 10b5-1 trading plan, and a Form 4 does not always make clear which applies.

Transactions reported on this filing
Code Nature Shares Price Value
S Open-market sale 279,644 $19.81 $5.54M
S Open-market sale 18,356 $20.65 $379.0K
Filing: Form 4 (Insider Transaction) Insider: KAO JOHN E (Director, Chief Executive Officer) Shares: 298,000 Est. Value: $5.92M
View on SEC EDGAR → Open Filing Document →
Proposed Insider Sales 8 · Form 144

A Form 144 is a notice of intent to sell restricted or control securities. It is not a record that anything was sold. Alignment Healthcare, Inc. has 8 such notices in this period.

The distinction matters because a Form 144 is frequently reported as though it were a completed insider sale. The filer may sell all of the shares covered, some of them, or none at all, and there is no obligation to update the notice either way. A sale that is actually executed by an officer or director shows up separately on a Form 4, which is the filing to check before treating a proposed sale as a real one.

Form 144 Proposed Insider Sale 2026-10-05

ALHC Form 144 filed for proposed insider sale by Hyong (Ken) Kim, M.D. (36,000 shares) ~$305.3K

Hyong (Ken) Kim, M.D. filed a Form 144 with the SEC indicating intent to sell ALHC (Alignment Healthcare, Inc.) shares. Form 144 reflects a proposed sale, not a completed transaction. The actual execution, if any, would typically appear later in a Form 4.

Filing: Form 144 (Proposed Sale Notice) Insider: Hyong (Ken) Kim, M.D. Shares: 36,000 Est. Value: $305.3K
View on SEC EDGAR → Open Filing Document →
Form 144 Proposed Insider Sale 2026-09-16

ALHC Form 144 filed for proposed insider sale by Joseph Konowiecki (26,000 shares) ~$226.5K

Joseph Konowiecki filed a Form 144 with the SEC indicating intent to sell ALHC (Alignment Healthcare, Inc.) shares. Form 144 reflects a proposed sale, not a completed transaction. The actual execution, if any, would typically appear later in a Form 4.

Filing: Form 144 (Proposed Sale Notice) Insider: Joseph Konowiecki Shares: 26,000 Est. Value: $226.5K
View on SEC EDGAR → Open Filing Document →
Form 144 Large Proposed Insider Sale 2026-09-10

ALHC Form 144 filed for proposed insider sale by JEK TRUST U/A DTD 02/08/2021 (500,000 shares) ~$6.51M

JEK TRUST U/A DTD 02/08/2021 filed a Form 144 with the SEC indicating intent to sell ALHC (Alignment Healthcare, Inc.) shares. Form 144 reflects a proposed sale, not a completed transaction. The actual execution, if any, would typically appear later in a Form 4. The proposed dollar value is large enough to merit attention.

Filing: Form 144 (Proposed Sale Notice) Insider: JEK TRUST U/A DTD 02/08/2021 Shares: 500,000 Est. Value: $6.51M
View on SEC EDGAR → Open Filing Document →
Form 144 Proposed Insider Sale 2026-09-09

ALHC Form 144 filed for proposed insider sale by Dawn C. Maroney (130,000 shares) ~$1.70M

Dawn C. Maroney filed a Form 144 with the SEC indicating intent to sell ALHC (Alignment Healthcare, Inc.) shares. Form 144 reflects a proposed sale, not a completed transaction. The actual execution, if any, would typically appear later in a Form 4.

Filing: Form 144 (Proposed Sale Notice) Insider: Dawn C. Maroney Shares: 130,000 Est. Value: $1.70M
View on SEC EDGAR → Open Filing Document →
Form 144 Large Proposed Insider Sale 2026-09-09

ALHC Form 144 filed for proposed insider sale by John Kao (405,000 shares) ~$5.29M

John Kao filed a Form 144 with the SEC indicating intent to sell ALHC (Alignment Healthcare, Inc.) shares. Form 144 reflects a proposed sale, not a completed transaction. The actual execution, if any, would typically appear later in a Form 4. The proposed dollar value is large enough to merit attention.

Filing: Form 144 (Proposed Sale Notice) Insider: John Kao Shares: 405,000 Est. Value: $5.29M
View on SEC EDGAR → Open Filing Document →
Form 144 Proposed Insider Sale 2026-08-14

ALHC Form 144 filed for proposed insider sale by DAWN MARONEY (5,000 shares) ~$67.3K

DAWN MARONEY filed a Form 144 with the SEC indicating intent to sell ALHC (Alignment Healthcare, Inc.) shares. Form 144 reflects a proposed sale, not a completed transaction. The actual execution, if any, would typically appear later in a Form 4.

Filing: Form 144 (Proposed Sale Notice) Insider: DAWN MARONEY Shares: 5,000 Est. Value: $67.3K
View on SEC EDGAR → Open Filing Document →
Form 144 Proposed Insider Sale 2026-07-15

ALHC Form 144 filed for proposed insider sale by DAWN MARONEY (177,068 shares) ~$3.75M

DAWN MARONEY filed a Form 144 with the SEC indicating intent to sell ALHC (Alignment Healthcare, Inc.) shares. Form 144 reflects a proposed sale, not a completed transaction. The actual execution, if any, would typically appear later in a Form 4.

Filing: Form 144 (Proposed Sale Notice) Insider: DAWN MARONEY Shares: 177,068 Est. Value: $3.75M
View on SEC EDGAR → Open Filing Document →
Form 144 Large Proposed Insider Sale 2026-07-10

ALHC Form 144 filed for proposed insider sale by JEK TRUST U/A DTD 02/08/2021 (596,000 shares) ~$12.53M

JEK TRUST U/A DTD 02/08/2021 filed a Form 144 with the SEC indicating intent to sell ALHC (Alignment Healthcare, Inc.) shares. Form 144 reflects a proposed sale, not a completed transaction. The actual execution, if any, would typically appear later in a Form 4. The proposed dollar value is large enough to merit attention.

Filing: Form 144 (Proposed Sale Notice) Insider: JEK TRUST U/A DTD 02/08/2021 Shares: 596,000 Est. Value: $12.53M
View on SEC EDGAR → Open Filing Document →
Material Events 2 · Form 8-K

An 8-K reports a material event in the window between scheduled reports. There are 2 in this period for Alignment Healthcare, Inc. Each 8-K names the item number it is filed under, and that number is the fastest way to tell a routine disclosure from a consequential one.

Item 2.02 is an earnings release, Item 5.02 is a change of directors or officers, and Item 1.01 or 2.01 covers a material agreement or a completed acquisition. Item 7.01 and Item 8.01 are the general-purpose disclosure items and carry no fixed meaning on their own.

Form 8-K Material Company Update 2026-10-08

ALHC filed 8-K — material company event

Alignment Healthcare, Inc. filed an 8-K with the SEC reporting a material event. Summary unavailable — view the original SEC filing for the full text.

Filing: 8-K (Material Event)
View on SEC EDGAR → Open Filing Document →
Form 8-K Material Company Update 2026-07-30

ALHC filed 8-K — material company event

Alignment Healthcare, Inc. filed an 8-K with the SEC reporting a material event. Summary unavailable — view the original SEC filing for the full text.

Filing: 8-K (Material Event)
View on SEC EDGAR → Open Filing Document →
Periodic Reports 1 · Forms 10-K and 10-Q

The periodic reports are where the audited and reviewed financial statements live. This period contains 1 quarterly report (10-Q) for Alignment Healthcare, Inc.

The two are not equivalent in weight. A 10-K is audited by an external firm and includes the full risk factor disclosure, business description and management discussion; a 10-Q is unaudited, reviewed rather than examined, and much shorter. When a figure in a quarterly report is later revised, the annual report is usually where the correction appears.

An amended report — 10-K/A or 10-Q/A — restates or corrects something in the original filing, and is worth reading against the version it replaces.

Form 10-Q Quarterly Report 2026-07-30

ALHC filed Quarterly Report (10-Q)

Alignment Healthcare, Inc. filed its quarterly report with the SEC. This report includes unaudited financial statements and management discussion for the quarter.

Filing: 10-Q (Quarterly Report)
View on SEC EDGAR → Open Filing Document →

How we classify Alignment Healthcare, Inc.'s filings

Straight from EDGAR

Each displayed record links to an original source document. StrongBuyAnalytics provides navigation and brief excerpts or summaries, not the filing itself. Parsing may omit context or contain errors, so read the original document in full.

Transaction codes, not guesswork

The nature shown on each insider filing comes from the transaction code the filer entered on the form itself — P for an open-market purchase, A for a compensation award, F for shares withheld to pay tax, M for an option exercise. Where one filing contains several codes, the transaction table lists them line by line.

Why the distinction matters

Insider activity is routinely summarised as buying or selling, which flattens together decisions that mean very different things. Shares withheld for tax on a vesting grant are an automatic administrative step; shares bought on the open market are someone committing their own money at the current price.

What this page does not tell you

A filing records what happened, not why. Form 4 does not always disclose whether a sale was executed under a pre-arranged Rule 10b5-1 plan, and no single filing is a basis for a decision on ALHC. Read these alongside the fundamentals rather than in isolation.

Frequently Asked Questions — ALHC SEC Filings

More Tools for ALHC

ALHC Full Stock Analysis ALHC Live Chart Institutional Ownership Earnings Calendar Options Flow Scanner Semiconductor Demand Zone Tracker Sector Scanner Browse All Stocks

Want deeper ALHC analysis?

View valuation, growth metrics, the rule-based stock-page score, demand zones, peer comparison, and more — all on the ALHC stock analysis page.

ALHC Full Analysis
Publisher, sources & limitations — September 15, 2026. StrongBuyAnalytics provides navigation and brief excerpts or summaries for educational use. Original filings remain at SEC EDGAR or other displayed source links; StrongBuyAnalytics does not author them. Filing dates are source dates, not publication dates for this page. Coverage can be delayed, incomplete, amended, or unavailable because of SEC/source availability, parsing, caching, or outages. Verify every material statement in the original filing.
Data Sources · Methodology · AI Disclosure · Corrections Policy · Disclaimer